Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 4, 2026
- Zimmer Biomet Holdings, Inc. reported third-quarter net sales of $2.063 billion, up 3.7% on a constant currency basis, and raised 2026 organic constant-currency revenue growth guidance to 3.0% - 3.5%. Adjusted diluted EPS was $1.90, consistent with the prior year period.
- 10-Q report · filed Nov 4, 2026
- Zimmer Biomet reported three-month net sales growth of 3.1% and nine-month growth of 5.7%. Nine-month net earnings reached $628.1 million, while three-month net earnings fell to $191.6 million from $230.9 million.
The audio replay and transcript follow the call.